Hille Gieschen

603 total citations
16 papers, 455 citations indexed

About

Hille Gieschen is a scholar working on Pulmonary and Respiratory Medicine, Pharmacology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hille Gieschen has authored 16 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Pharmacology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hille Gieschen's work include Prostate Cancer Treatment and Research (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Hille Gieschen is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Hille Gieschen collaborates with scholars based in Germany, Finland and France. Hille Gieschen's co-authors include Christian Zurth, D. Seidel, W. Kuhnz, Joachim Höchel, Olaf Prien, Mikko Koskinen, Hans‐Hubert Borchert, Robert E. Fricke, Steffen Sandmann and Timo Korjamo and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Analytical Biochemistry.

In The Last Decade

Hille Gieschen

16 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hille Gieschen Germany 12 219 105 101 90 72 16 455
Benjamin P. Haynes United Kingdom 11 238 1.1× 137 1.3× 77 0.8× 154 1.7× 142 2.0× 14 530
Aakanksha Khandelwal United States 11 127 0.6× 81 0.8× 26 0.3× 276 3.1× 66 0.9× 14 488
Olaf Prien Germany 10 141 0.6× 56 0.5× 68 0.7× 98 1.1× 41 0.6× 16 353
Senthilmurugan Ramalingam United States 11 198 0.9× 63 0.6× 20 0.2× 274 3.0× 63 0.9× 13 439
Karsten Denner Germany 11 93 0.4× 108 1.0× 33 0.3× 323 3.6× 208 2.9× 19 660
Aashvini Belosay United States 10 114 0.5× 57 0.5× 23 0.2× 269 3.0× 65 0.9× 12 446
Edward Licitra United States 8 203 0.9× 221 2.1× 50 0.5× 400 4.4× 31 0.4× 13 838
Alicja Puszkiel France 10 50 0.2× 134 1.3× 27 0.3× 106 1.2× 23 0.3× 29 304
BA Parker United States 6 46 0.2× 141 1.3× 96 1.0× 110 1.2× 21 0.3× 8 440
Sandra R. B. Allerheiligen United States 11 107 0.5× 215 2.0× 23 0.2× 186 2.1× 20 0.3× 16 586

Countries citing papers authored by Hille Gieschen

Since Specialization
Citations

This map shows the geographic impact of Hille Gieschen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hille Gieschen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hille Gieschen more than expected).

Fields of papers citing papers by Hille Gieschen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hille Gieschen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hille Gieschen. The network helps show where Hille Gieschen may publish in the future.

Co-authorship network of co-authors of Hille Gieschen

This figure shows the co-authorship network connecting the top 25 collaborators of Hille Gieschen. A scholar is included among the top collaborators of Hille Gieschen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hille Gieschen. Hille Gieschen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Taavitsainen, Päivi, Olaf Prien, Michael Niehues, et al.. (2021). Metabolism and Mass Balance of the Novel Nonsteroidal Androgen Receptor Inhibitor Darolutamide in Humans. Drug Metabolism and Disposition. 49(6). 420–433. 9 indexed citations
2.
Taavitsainen, Päivi, Hille Gieschen, Timo Korjamo, et al.. (2020). Absorption, distribution, metabolism and excretion of darolutamide (a novel non-steroidal androgen receptor antagonist) in rats. Xenobiotica. 50(8). 967–979. 9 indexed citations
3.
Zurth, Christian, Mikko Koskinen, Robert E. Fricke, et al.. (2019). Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies. European Journal of Drug Metabolism and Pharmacokinetics. 44(6). 747–759. 71 indexed citations
4.
Zane, Patricia, Hille Gieschen, Neil Mathias, et al.. (2019). In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical development. European Journal of Pharmaceutics and Biopharmaceutics. 142. 222–231. 19 indexed citations
5.
6.
Zurth, Christian, Karim Fizazi, Robert E. Fricke, et al.. (2019). Assessing the clinical relevance of drug-drug interactions (DDI) with darolutamide (DARO). Annals of Oncology. 30. v350–v350. 3 indexed citations
7.
Zurth, Christian, et al.. (2019). Higher blood–brain barrier penetration of [14C]apalutamide and [14C]enzalutamide compared to [14C]darolutamide in rats using whole-body autoradiography.. Journal of Clinical Oncology. 37(7_suppl). 156–156. 39 indexed citations
8.
Zurth, Christian, et al.. (2018). Blood-brain barrier penetration of [14C]darolutamide compared with [14C]enzalutamide in rats using whole body autoradiography.. Journal of Clinical Oncology. 36(6_suppl). 345–345. 40 indexed citations
9.
Höchel, Joachim, et al.. (2009). Improving the ex vivo stability of drug ester compounds in rat and dog serum: Inhibition of the specific esterases and implications on their identity. Journal of Pharmaceutical and Biomedical Analysis. 51(3). 664–678. 35 indexed citations
10.
Höchel, Joachim, et al.. (2008). Determination of rat serum esterase activities by an HPLC method using S-acetylthiocholine iodide and p-nitrophenyl acetate. Analytical Biochemistry. 381(1). 113–122. 18 indexed citations
11.
Hoffmann, Jens, Rolf Bohlmann, H. Hofmeister, et al.. (2004). Characterization of New Estrogen Receptor Destabilizing Compounds: Effects on Estrogen-Sensitive and Tamoxifen-Resistant Breast Cancer. JNCI Journal of the National Cancer Institute. 96(3). 210–218. 66 indexed citations
12.
Oscier, David, Jennifer Orchard, Dominic Culligan, et al.. (2001). The bioavailability of oral fludarabine phosphate is unaffected by food. The Hematology Journal. 2(5). 316–321. 26 indexed citations
13.
Kuhnz, W. & Hille Gieschen. (1998). Predicting the oral bioavailability of 19-nortestosterone progestins in vivo from their metabolic stability in human liver microsomal preparations in vitro.. PubMed. 26(11). 1120–7. 26 indexed citations
14.
Gieschen, Hille, et al.. (1997). Development of a V79 cell line expressing human cytochrome P450 2D6 and its application as a metabolic screening tool. Environmental Toxicology and Pharmacology. 3(1). 31–39. 3 indexed citations
15.
Gieschen, Hille, et al.. (1995). Stable expression of human cytochrome P450 3A4 in V79 cells and its application for metabolic profiling of ergot derivatives. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 293(3). 183–190. 12 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin P. Haynes Breakdown of academic impact, for papers by Aakanksha Khandelwal Breakdown of academic impact, for papers by Olaf Prien Breakdown of academic impact, for papers by Senthilmurugan Ramalingam Breakdown of academic impact, for papers by Karsten Denner Breakdown of academic impact, for papers by Aashvini Belosay Breakdown of academic impact, for papers by Edward Licitra Breakdown of academic impact, for papers by Alicja Puszkiel Breakdown of academic impact, for papers by BA Parker Breakdown of academic impact, for papers by Sandra R. B. Allerheiligen
Rankless by CCL
2026